ARTICLE | Company News
Actavis, TPG Capital deal
February 16, 2015 8:00 AM UTC
Actavis will divest its Aptalis Pharmaceutical Technologies outsourcing and R&D business to private investment firm TPG for an undisclosed sum. The deal is expected to close by mid-year. Actavis said ...